Overview of Program
About the Concentration
The Department of Pharmacology and Neuroscience offers graduate programs leading to the M.S. and Ph.D. degree in Translational Neuroscience and Pharmacology. Graduate study may be pursued in several areas, including systems and cellular neuropharmacology and neuroscience, molecular pharmacology, biochemistry and neurobiology of disease. The newly established Center of Excellence for Translational Neuroscience and Therapeutics provides valuable opportunities for interdisciplinary basic science and translational research. Clinically relevant research topics include pain mechanisms and therapies in various preclinical models (arthritis, multiple sclerosis (MS), HIV, chemotherapy- and nerve injury-induced neuropathic pain), alcohol abuse disorders, alcohol- and oxidative stress-induced damage to the developing brain and neurodegeneration, neurodegenerative disorders such as Alzheimer’s Disease, anti-neoplastic drug development and mechanisms of drug resistance.
The M.S. degree is a two-year program. The first year consists primarily of coursework (first year curriculum) as well as lab rotations. The second year consists almost entirely of research culminating in a master's dissertation and oral defense.
A minimum of three years of graduate study beyond the bachelor's degree is required for the Ph.D. degree; completion of the requirements generally takes four to five years. During the period of study, the student does the required course work, takes a qualifying examination, and completes a Ph.D. dissertation based on his or her original research.
The faculty members of the program seek to foster a creative and productive research atmosphere and to equip students with the intellectual tools they will need to succeed as investigators and teachers. Graduates can expect to enter careers in academic institutions, industry, or government agencies.
Opportunities are also available for postdoctoral training in the research areas listed above.